Next generation sequencing Archives

dna sequencing covid 19 vaccine funding european biotech investment

News and Trends 10 Jun 2021

The Top European Biotech Investment Rounds in May

Last month saw huge biotech investment rounds dedicated to Covid-19 vaccines in Europe, including IPOs by Valneva and Vaccitech. However, a €227M (£195M) private round by the DNA sequencing giant Oxford Nanopore Technologies made the biggest splash. Last month was a difficult one for a number of public biotech companies. Biotech stock indices proved volatile […]

June 10, 2021 - 4 minutesmins - By Jonathan Smith

spatial transcriptomics 10x genomics readcoor

In Depth 12 May 2021

Spatial Transcriptomics: A Window into Disease

The emerging spatial transcriptomics field is letting researchers map out gene expression in tumor and brain samples. How could this change the way we treat disease? DNA and RNA sequencing technology has undergone a revolution in the last decade, with companies working to provide ever cheaper and faster ways to explore our genetics. This stride […]

May 12, 2021 - 8 minutesmins - By Jonathan Smith

News and Trends 18 Mar 2021

Europe Falls Behind in Efforts to Track Covid-19 Variants

As barely a third of European countries meet targets to track concerning Covid-19 variants, diagnostics and genomics companies are scrambling to help them tackle this challenge. New strains of the Covid-19 coronavirus are sweeping Europe as vaccine distribution efforts roll on. These variants often gain traction when mutations let them become more virulent or spread […]

March 18, 2021 - 5 minutesmins - By Anita Chakraverty

Single Cell Sequencing Precision Medicine

In Depth 27 Jan 2021

Single-Cell Sequencing: Paving the Way for Precision Medicine

Next-generation sequencing techniques to determine an individual’s unique genetic code gave rise to personalized treatments. Single-cell sequencing is the next step towards making precision medicine more accurate. Each cell in our body is unique. Even genetically identical cells can behave differently in response to a certain treatment. With next-generation sequencing, scientists can study how the […]

January 27, 2021 - 7 minutesmins - By Timothé Cynober

In Depth 8 Jun 2020

Regulations on Genetic Data Could Threaten Genomics Innovation

As genetic research relies more and more on digital technology, international regulations are straining to catch up and some fear they threaten to stifle innovation. Is it possible to develop a regulatory framework for genetic data that is fair for everyone? In just a couple decades, the digital revolution has taken over all sorts of […]

June 8, 2020 - 6 minutesmins - By External Contributor

In Depth 1 Jun 2020

How Personal Genomics Companies Are Changing Drug Development

In recent years, companies offering direct-to-consumer genomics tests have started switching the business model and venturing into drug development. Amidst criticism on data protection and lack of transparency, personal genomics companies are leveraging their unique position to generate genomics data to strike lucrative deals with pharma companies. Thanks to cheaper data acquisition and convenient analysis, […]

June 1, 2020 - 6 minutesmins - By Timothé Cynober

genomics machine learning personalized medicine

News and Trends 8 May 2020

€7M Series A To Democratize Genomics with AI-Driven Cloud Software

The UK-based bioinformatics firm Lifebit Biotech has closed a €7M Series A funding round, which will help the startup to accelerate the global market expansion of its AI-driven, cloud-based genomics analysis software. The round was led by the Parisian VC firm Idinvest Partners and also included returning investors Pentech Ventures, Beacon Capital, and Connect Ventures. […]

May 8, 2020 - 3 minutesmins - By Laura Cowen

scipio bioscience single cell sequencing

News and Trends 26 Feb 2020

French Startup Raises €6M to Develop Cheap Single-Cell Sequencing Kits

Scipio bioscience has raised €6M in a Series A round to launch cost-effective single-cell RNA sequencing kits, which could have big potential in profiling cells for research and clinical diagnostics. The round was led by M Ventures, the corporate venture capital arm of Merck. Other investors in the round included Seventure Partners’ seed fund Quadrivum […]

February 26, 2020 - 2 minutesmins - By Jonathan Smith

News and Trends 25 Feb 2020

Update: Janssen and Maze Jump on Board Finnish Genomics Project

Update (25/02/2020): Janssen and the US company Maze Therapeutics are the latest pharma companies to sign up as partners in the public-private genomics collaboration FinnGen. FinnGen’s pharma partners now total 11, including Sanofi and GSK, which joined early last year. Published 23/01/2019: Sanofi and GSK have joined up with a project collecting genomic and health […]

February 25, 2020 - 3 minutesmins - By Jonathan Smith

Interview 12 Feb 2020

Boosting Cancer Research by Unlocking Genomic Data

More genomic data is produced today than ever before as it’s fundamental to the development of new medicines. But although there is a lot of data out there, much of it is inaccessible. With a background in computer science and bioinformatics, Fiona Nielsen, co-founder and CEO of Repositive, decided to overcome this bottleneck and open […]

February 12, 2020 - 6 minutesmins - By Larissa Warneck-Silvestrin

News and Trends 31 Oct 2019

European Project Launches to Tailor Autoimmune Disease Treatments

Public and private organizations across Europe will pool their resources in an €80M project to discover biomarkers that can predict which patients will respond best to treatments for autoimmune diseases. The project is called Taxonomy, Treatments, Targets and Remission, or 3TR for short, and is funded by the EU’s Innovative Medicines Initiative for the next […]

October 31, 2019 - 2 minutesmins - By Jonathan Smith

deCODE genetics whole genome sequencing uk biobank

News and Trends 13 Sep 2019

Icelandic Company to Sequence 225,000 Genomes from UK Patients

The Icelandic genomics company deCODE genetics has joined the UK’s Wellcome Sanger Institute in sequencing 450,000 genomes as part of a massive €224M (£200M) project organized by the UK Biobank initiative. The UK Biobank’s €224M grant includes €56M (£50M) from the UK government, €56M from the UK’s Wellcome Trust charity, and €112M (£100M) from big […]

September 13, 2019 - 3 minutesmins - By Jonathan Smith

Resources

Categories

The biggest private biotech investments in August 2024

Long non-coding RNAs: what’s behind the growing “dark genome” buzz?

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

Six biotech companies that could revolutionize obesity treatments

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us